PDCD1 and Arthritis: The first group comprised patients who developed arthritis after PD-1 inhibitor monotherapy (hereafter, PD-1 inhibitor arthritis) and the other group comprised patients who developed arthritis after combined ICI therapy (hereafter, combined ICI arthritis).